Bolt Biotherapeutics, Inc.
Recent Filings
All 273 filings →| Form | Description | Date |
|---|---|---|
| S-8 | S-8 | Mar 12, 2026 |
| 10-K | 10-K | Mar 12, 2026 |
| 8-K | 8-K | Mar 12, 2026 |
| SCHEDULE 13D/A | — | Feb 26, 2026 |
| SCHEDULE 13D/A | — | Feb 17, 2026 |
| SCHEDULE 13G/A | — | Feb 13, 2026 |
| 4 | 4 | Feb 4, 2026 |
| 4 | 4 | Feb 4, 2026 |
| 4 | 4 | Feb 4, 2026 |
| 4 | 4 | Dec 16, 2025 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Nemec Sarah | Senior VP, Finance and PAO | Purchase | 125 @ $5.49 | 943 | Oct 22, 2025 |
| Yonehiro Grant | Chief Operating Officer | Award / Grant | 30,000 | 38,918 | Oct 22, 2025 |
| Quinn William P. | President, CEO and CFO | Award / Grant | 40,000 | 42,188 | Jun 6, 2025 |
| Nemec Sarah | Senior VP, Finance and PAO | Purchase | 2,500 @ $0.64 | 13,863 | Dec 16, 2024 |
| Quinn William P. | President, CEO and CFO | Purchase | 2,500 @ $0.50 | 41,272 | Jun 6, 2024 |
| Quinn William P. | Chief Financial Officer | Purchase | 1,829 @ $1.18 | 26,272 | Dec 12, 2023 |
| Yonehiro Grant | Chief Business Officer | Purchase | 2,500 @ $0.78 | 8,918 | Dec 6, 2023 |
| Perez Edith A. | Chief Medical Officer | Purchase | 2,070 @ $1.18 | 44,112 | Dec 6, 2023 |
| ENGLEMAN EDGAR | — | Sale | 108,145 @ $0.86 | 1,821,483 | Nov 29, 2023 |
| ENGLEMAN EDGAR | — | Sale | 1,707 @ $0.90 | 1,952,302 | Nov 21, 2023 |